HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Goodpasture's syndrome — Clinical Guidelines

Overview

Goodpasture's syndrome is a rare autoimmune disorder characterized by the formation of antibodies against the non-collagenous domain of type IV collagen, leading to pulmonary hemorrhage and glomerulonephritis. 1 2

Diagnosis

Clinical Presentation: Pulmonary symptoms (hemoptysis) and renal involvement (hematuria, proteinuria, rapidly progressive glomerulonephritis).

Laboratory Tests: Anti-glomerular basement membrane (anti-GBM) antibodies in serum and/or renal biopsy showing linear IgG deposition along the glomerular basement membrane.

Imaging: Chest imaging may reveal pulmonary infiltrates or alveolar hemorrhage.

Renal Biopsy: Essential for confirming the diagnosis and assessing the extent of renal damage. 1 2

Management

First-Line Treatment:

- Plasmapheresis: Recommended to remove circulating anti-GBM antibodies. 1 - Immunosuppressive Therapy: High-dose corticosteroids (e.g., prednisone) and cyclophosphamide (e.g., daily oral dose of 2 mg/kg for cyclophosphamide).

Adjunctive Treatments:

- Renal Replacement Therapy: Dialysis for acute kidney injury. - Mechanical Ventilation: For severe respiratory failure. - Bilateral Nephrectomy: Considered in cases with refractory disease or recurrent antibody production post-transplant. 3

Special Populations

Pediatrics: Extremely rare; often presents without pulmonary symptoms before puberty; poor prognosis with over 50% progressing to end-stage renal disease despite no reported deaths in the cohort studied. 2

Race/Ethnicity: Hispanics showed significantly lower use of plasmapheresis compared to other racial groups, suggesting potential disparities in treatment access or protocol adherence. 1

Key Recommendations

Initiate Plasmapheresis Early in the management of Goodpasture's syndrome to reduce circulating anti-GBM antibodies. (Evidence: Moderate) 1

Use High-Dose Corticosteroids and Cyclophosphamide as the cornerstone immunosuppressive therapy. (Evidence: Moderate) 2 3

Consider Mechanical Ventilation and Renal Replacement Therapy based on clinical severity of respiratory and renal failure. (Evidence: Weak) 3

References

1 Cheungpasitporn W, Thongprayoon C, Mao MA, Boonpheng B, Bathini T, Vallabhajosyula S et al.. The impact of race on hospitalization outcomes for goodpasture's syndrome in the United States: nationwide inpatient sample 2003-2014. Hospital practice (1995) 2021. link 2 Menzi CP, Bucher BS, Bianchetti MG, Ardissino G, Simonetti GD. Management and outcomes of childhood Goodpasture's disease. Pediatric research 2018. link 3 Löcsey L, Kakuk G, Wórum I, Wórum F, Szabó J, Kovács P et al.. Goodpasture's syndrome: haemodialysis, pacing and extrapulmonary oxygenation. Acta medica Academiae Scientiarum Hungaricae 1980. link

Goodpasture's syndrome